Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HIV type 1 coreceptors, neutralization serotypes, and vaccine development.

× No keyword cloud information.

13 in total

1. HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.

Authors: H Ueda; O M Howard; M C Grimm; S B Su; W Gong; G Evans; F W Ruscetti; J J Oppenheim; J M Wang
Journal: J Clin Invest Date: 1998-08-15 Impact factor: 14.808

2. Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques.

Authors: Angela M Amedee; Whitney A Nichols; Nicole J LeCapitaine; Curtis Vande Stouwe; Leslie L Birke; Nedra Lacour; Peter J Winsauer; Patricia E Molina
Journal: AIDS Res Hum Retroviruses Date: 2014-12 Impact factor: 2.205

3. Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.

Authors: Xinzhen Yang; Svetla Kurteva; Sandra Lee; Joseph Sodroski
Journal: J Virol Date: 2005-03 Impact factor: 5.103

4. Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.

Authors: D Del Mauro; D Matteucci; S Giannecchini; F Maggi; M Pistello; M Bendinelli
Journal: J Virol Date: 1998-03 Impact factor: 5.103

5. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.

Authors: Xinzhen Yang; Svetla Kurteva; Xinping Ren; Sandra Lee; Joseph Sodroski
Journal: J Virol Date: 2005-10 Impact factor: 5.103

6. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.

Authors: Y Zhang; B Lou; R B Lal; A Gettie; P A Marx; J P Moore
Journal: J Virol Date: 2000-08 Impact factor: 5.103

Review 7. Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.

Authors: Yi Xiao; Xiaonan Dong; Ying-Hua Chen
Journal: Immunol Res Date: 2002 Impact factor: 2.829

8. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors: F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal: J Virol Date: 1998-07 Impact factor: 5.103

9. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Authors: P Mazzetti; S Giannecchini; D Del Mauro; D Matteucci; P Portincasa; A Merico; C Chezzi; M Bendinelli
Journal: J Virol Date: 1999-01 Impact factor: 5.103

10. Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses.

Authors: J D Trujillo; N M Kumpula-McWhirter; K J Hötzel; M Gonzalez; W P Cheevers
Journal: J Virol Date: 2004-09 Impact factor: 5.103